This is filed to report post mitraclip procedure,hypoxia, atrial perforation, shock cardiogenic, cardiac arrest, hypertension, heart failure, worsening tricuspid regurgitation, recurrent mitral regurgitation, and rehospitalization occurred.It was reported through a research article identifying the mitraclip device which may be related to patient hypoxia, atrial perforation, shock cardiogenic, cardiac arrest, hypertension, heart failure, worsening tricuspid regurgitation, recurrent mitral regurgitation, and rehospitalization.Specific patient information is documented as unknown.Details are listed in the attached article, iatrogenic atrial septal defect following the mitraclip procedure: a state-of-the-art review.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record could not be performed as lot and part number was not provided.Based on the information available, a definitive cause for the reported patient effects could not be determined.The patient effects of atrial perforation, shock cardiogenic, cardiac arrest, hypertension, heart failure and mitral regurgitation are listed in the mitraclip instructions for use as known possible complications associated with mitraclip procedures.Hospitalization were a result of case-specific circumstances as the patient was re-hospitalized.Although a conclusive cause for the reported patient effects and the relationship to the device, if any, cannot be determined, there is no indication of a product issue with respect to manufacture, design or labeling.
|